Showing results (341-350 of 561) with videos related to

Sort By:
Pageof 57
Journal of Clinical Medicine|July 1, 2020
Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched SubtypesNeil K Jairath, Mark W Farha, Sudharsan Srinivasan, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
The Spine Journal : Official Journal of the North American Spine Society|September 2, 2015
Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastasesDaniel E Spratt, Julio Arevalo-Perez, Jonathan E Leeman, et al.
Medical Oncology (Northwood, London, England)|July 24, 2019
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution seriesJohn M Kennedy, Xiaoming Wang, Komal R Plouffe, et al.
BJU International|June 6, 2017
Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution studyVasu Tumati, William C Jackson, Ahmed E Abugharib, et al.
European Urology|July 19, 2017
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerDaniel E Spratt, Robert T Dess, Zachary S Zumsteg, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2012
International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgeryBrett W Cox, Daniel E Spratt, Michael Lovelock, et al.
JCO Precision Oncology|August 25, 2020
Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate CancerSimpa S Salami, Udit Singhal, Daniel E Spratt, et al.
EJNMMI Research|January 24, 2016
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modelingEdward K Fung, Sarah M Cheal, Shoaib B Fareedy, et al.
European Urology|March 9, 2023
Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 TrialSoumyajit Roy, Yilun Sun, Scott C Morgan, et al.
Pageof 57